Unknown

Dataset Information

0

Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain.


ABSTRACT: Somatostatin released from the capsaicin-sensitive sensory nerves mediates analgesic and anti-inflammatory effects via the somatostatin sst4 receptor without endocrine actions. Therefore, sst4 is considered to be a novel target for drug development in pain including chronic neuropathy, which is an emerging unmet medical need. Here, we examined the in silico binding, the sst4-linked G-protein activation on stable receptor expressing cells (1 nM to 10 ?M), and the effects of our novel pyrrolo-pyrimidine molecules in mouse inflammatory and neuropathic pain models. All four of the tested compounds (C1-C4) bind to the same binding site of the sst4 receptor with similar interaction energy to high-affinity reference sst4 agonists, and they all induce G-protein activation. C1 is the more efficacious (?-GTP-binding: 218.2% ± 36.5%) and most potent (EC50: 37 nM) ligand. In vivo testing of the actions of orally administered C1 and C2 (500 µg/kg) showed that only C1 decreased the resiniferatoxin-induced acute neurogenic inflammatory thermal allodynia and mechanical hyperalgesia significantly. Meanwhile, both of them remarkably reduced partial sciatic nerve ligation-induced chronic neuropathic mechanical hyperalgesia after a single oral administration of the 500 µg/kg dose. These orally active novel sst4 agonists exert potent anti-hyperalgesic effect in a chronic neuropathy model, and therefore, they can open promising drug developmental perspectives.

SUBMITTER: Kantas B 

PROVIDER: S-EPMC6940912 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain.

Kántás Boglárka B   Börzsei Rita R   Szőke Éva É   Bánhegyi Péter P   Horváth Ádám Á   Hunyady Ágnes Á   Borbély Éva É   Hetényi Csaba C   Pintér Erika E   Helyes Zsuzsanna Z  

International journal of molecular sciences 20191211 24


Somatostatin released from the capsaicin-sensitive sensory nerves mediates analgesic and anti-inflammatory effects via the somatostatin sst<sub>4</sub> receptor without endocrine actions. Therefore, sst<sub>4</sub> is considered to be a novel target for drug development in pain including chronic neuropathy, which is an emerging unmet medical need. Here, we examined the in silico binding, the sst<sub>4</sub>-linked G-protein activation on stable receptor expressing cells (1 nM to 10 μM), and the  ...[more]

Similar Datasets

| S-EPMC2799253 | biostudies-literature
| S-EPMC10160452 | biostudies-literature
| S-EPMC4138931 | biostudies-literature
| S-EPMC5474949 | biostudies-literature
2019-09-12 | GSE135080 | GEO
| S-EPMC8310002 | biostudies-literature
| S-EPMC3582300 | biostudies-other
| S-EPMC7426910 | biostudies-literature
| S-EPMC10473735 | biostudies-literature
| S-EPMC5559271 | biostudies-literature